Brief: Janone Completes Pre-Ind Meeting With FDA On Jan123

AI Financial

18/04/2023 13:36

April 18 (Reuters) - Janone Inc  JAN.O :
    * JANONE COMPLETES PRE-IND MEETING WITH FDA ON JAN123
    * JANONE INC: COMPANY NOW HAS PATHWAY TOWARD FORMAL DRUG
APPLICATION FOR  JAN123
    * JANONE COMPLETES PRE-IND MEETING WITH FDA ON JAN123
    * JANONE INC: AGENCY'S FEEDBACK WILL BE USED TO MOVE JAN123
TOWARD
A NEW DRUG APPLICATION UNDER A 505-B2 DESIGNATION

Source text for Eikon:  ID:nPn1Zg2c8a 
Further company coverage:  JAN.O